Rizzi; James P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rizzi; James P..The latest application filed is for "cd73 inhibitors and uses thereof".
Company Profile
7.33.24
- Rizzi; James P. - Aurora CO
- Rizzi; James P. - Irving TX
- Rizzi; James P. - Addison TX
- Rizzi; James P. - Boulder CO US
- Rizzi; James P. - Longmont CO
- Rizzi; James P. - Niwot CO
- Rizzi; James P. - Waterford CT
- Rizzi; James P. - Groton CT
Patent Activity
| Patent | Date |
|---|---|
| Cd73 Inhibitors And Uses Thereof App 20210317150 - Wang; Bin ; et al. | 2021-10-14 |
| Compositions And Methods For Inhibiting Cd73 App 20210253614 - Wang; Bin ; et al. | 2021-08-19 |
| Aromatic compounds and uses thereof Grant 10,807,948 - Dixon , et al. October 20, 2 | 2020-10-20 |
| Aryl Ethers And Uses Thereof App 20200190031 - Dixon; Darryl David ; et al. | 2020-06-18 |
| Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 10,669,269 - Boys , et al. | 2020-06-02 |
| Cd73 Inhibitors And Uses Thereof App 20200115404 - WANG; Bin ; et al. | 2020-04-16 |
| Aryl ethers and uses thereof Grant 10,597,366 - Dixon , et al. | 2020-03-24 |
| Aryl Ethers And Uses Thereof App 20190119214 - Dixon; Darryl David ; et al. | 2019-04-25 |
| Compositions for Use in Treating Pulmonary Arterial Hypertension App 20190015377 - Dixon; Darryl David ; et al. | 2019-01-17 |
| Aryl ethers and uses thereof Grant 10,144,711 - Dixon , et al. De | 2018-12-04 |
| Benzimidazole derivatives and uses thereof Grant 10,040,767 - Dixon , et al. August 7, 2 | 2018-08-07 |
| Aromatic Compounds And Uses Thereof App 20180162807 - DIXON; Darryl David ; et al. | 2018-06-14 |
| Aryl Ethers And Uses Thereof App 20180155279 - Dixon; Darryl David ; et al. | 2018-06-07 |
| Aryl ethers and uses thereof Grant 9,969,689 - Dixon , et al. May 15, 2 | 2018-05-15 |
| SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20180086758 - Boys; Mark Laurence ; et al. | 2018-03-29 |
| Aryl ethers and uses thereof Grant 9,908,845 - Dixon , et al. March 6, 2 | 2018-03-06 |
| Aryl ethers and uses thereof Grant 9,896,418 - Dixon , et al. February 20, 2 | 2018-02-20 |
| Cyclic sulfone and sulfoximine analogs and uses thereof Grant 9,884,843 - Dixon , et al. February 6, 2 | 2018-02-06 |
| Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,809,590 - Boys , et al. November 7, 2 | 2017-11-07 |
| Aryl Ethers And Uses Thereof App 20170217892 - Dixon; Darryl David ; et al. | 2017-08-03 |
| Aryl Ethers And Uses Thereof App 20170217891 - Dixon; Darryl David ; et al. | 2017-08-03 |
| Benzimidazole Derivatives And Uses Thereof App 20170088523 - DIXON; Darryl David ; et al. | 2017-03-30 |
| Cyclic Sulfone And Sulfoximine Analogs And Uses Thereof App 20160368893 - DIXON; Darryl David ; et al. | 2016-12-22 |
| Aryl Ethers And Uses Thereof App 20160251307 - DIXON; Darryl David ; et al. | 2016-09-01 |
| SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20160002232 - Boys; Mark Laurence ; et al. | 2016-01-07 |
| Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,174,981 - Boys , et al. November 3, 2 | 2015-11-03 |
| Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Grant 8,841,455 - Boys , et al. September 23, 2 | 2014-09-23 |
| Substituted N-(1h-indazol-4-yl)imidazo[1,2-]pyridine-3-carboxamide Compounds As Type Iii Receptor Tyrosine Kinase Inhibitors App 20130274244 - Boys; Mark Laurence ; et al. | 2013-10-17 |
| P38 inhibitors and methods of use thereof Grant 8,518,983 - Munson , et al. August 27, 2 | 2013-08-27 |
| Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors App 20120258952 - Boys; Mark Laurence ; et al. | 2012-10-11 |
| Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors Grant 8,138,181 - Allen , et al. March 20, 2 | 2012-03-20 |
| Kinase inhibitors and methods of use thereof Grant 8,044,083 - Groneberg , et al. October 25, 2 | 2011-10-25 |
| Kinase inhibitors and methods of use thereof Grant 8,039,639 - Groneberg , et al. October 18, 2 | 2011-10-18 |
| P38 inhibitors and methods of use thereof Grant 8,026,233 - Munson , et al. September 27, 2 | 2011-09-27 |
| P38 inhibitors and methods of use thereof Grant 8,017,641 - Munson , et al. September 13, 2 | 2011-09-13 |
| Kinase Inhibitors And Methods Of Use Thereof App 20110124878 - Groneberg; Robert ; et al. | 2011-05-26 |
| P38 inhibitors and methods of use thereof Grant 7,799,782 - Munson , et al. September 21, 2 | 2010-09-21 |
| IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS App 20100144751 - Marmsater; Fredrik P. ; et al. | 2010-06-10 |
| Imidazo[1,2-a]pyridine Compounds As Receptor Tyrosine Kinase Inhibitors App 20100029633 - Allen; Shelley ; et al. | 2010-02-04 |
| P38 Inhibitors And Methods Of Use Thereof App 20090149443 - Munson; Mark C. ; et al. | 2009-06-11 |
| Kinase Inhibitors And Methods Of Use Thereof App 20090023795 - Groneberg; Robert ; et al. | 2009-01-22 |
| Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents Grant 6,605,634 - Zablocki , et al. August 12, 2 | 2003-08-12 |
| Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents App 20030096819 - Zablocki, Jeffery A. ; et al. | 2003-05-22 |
| Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents Grant 6,440,973 - Zablocki , et al. August 27, 2 | 2002-08-27 |
| Compounds which inhibit tryptase activity Grant 6,362,216 - Burgess , et al. March 26, 2 | 2002-03-26 |
| Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents Grant 6,180,643 - Zablocki , et al. January 30, 2 | 2001-01-30 |
| Arylsulfonylamino hydroxamic acid derivatives Grant 5,994,351 - Robinson , et al. November 30, 1 | 1999-11-30 |
| Arylsulfonylamino hydroxamic acid derivatives Grant 5,863,949 - Robinson , et al. Ja | 1999-01-26 |
| Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors Grant 5,861,510 - Piscopio , et al. Ja | 1999-01-19 |
| Thiazolidinedione hypoglycemic agents Grant 5,223,522 - Clark , et al. June 29, 1 | 1993-06-29 |
| Thiazolidinedione hypoglycemic agents Grant 5,120,754 - Clark , et al. June 9, 1 | 1992-06-09 |
| Thiazolidinedione hypoglycemic agents Grant 5,061,717 - Clark , et al. October 29, 1 | 1991-10-29 |
| Arylthiazolylimidazoles Grant 4,914,207 - Nagel , et al. April 3, 1 | 1990-04-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 